XML 57 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Research and development, net $ 26,424 $ 20,890 $ 11,447
Marketing expenses 1,924 974 482
General and administrative 7,332 10,272 1,861
Total operating loss 35,680 32,136 13,790
Financial expenses (income), net (6,539) 1,606 13,474
Loss before taxes on income 29,141 33,742 27,264
Tax on income 16 20 7
Net loss 29,157 33,762 27,271
Net comprehensive loss $ 29,157 $ 33,762 $ 27,271
Net loss per share, basic and diluted (in Dollars per share) $ (0.42) $ (0.53) $ (0.67)
Weighted-average shares used in computing net loss per share, basic and diluted (in Shares) 69,377,922 63,534,875 40,534,697 [1]
[1] Prior period results have been retroactively adjusted to reflect the 1: 0.905292 stock split effected on March 7, 2022. See also note 12, Shareholders’ (deficiency) equity, for details.